Cilastatin / imipenem Pregnancy and Breastfeeding Warnings
Cilastatin / imipenem is also known as: Primaxin IM, Primaxin IV
Overview
If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Imipenem/Cilastatin while you are pregnant. It is not known if Imipenem/Cilastatin is found in breast milk. If you are or will be breast-feeding while you use Imipenem/Cilastatin, check with your doctor. Discuss any possible risks to your baby.
Cilastatin / imipenem Pregnancy Warnings
Imipenem-cilastatin has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of teratogenicity. However, some species experienced reduced maternal tolerance of the drug during pregnancy. There are no controlled data in human pregnancies. Imipenem-cilastatin should only be given during pregnancy when benefit outweighs risk.
Cilastatin / imipenem Breastfeeding Warnings
Imipenem-cilastatin is excreted into human milk in small amounts. The manufacturer recommends caution if imipenem-cilastatin is administered to a nursing woman.
See Also...
- Imipenem/Cilastatin Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
